Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT06919887

A Randomized Controlled Trial of Menopausal Tool/App for Women

The purpose of this study is about assessing the utilization of a mobile phone application (app), designed to improve the menopause experience of midlife women experiencing related symptoms and its association with menopause-related health care utilization

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

Menopausal Symptoms Menopause Symptom Management

Age range

24 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mayo Clinic

Rochester, Minnesota, 55905, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

For Patient Enrollment:

Inclusion criteria

  • Women between the ages of 45 and 55
  • English speaking (app only available in English)
  • Able to provide informed consent
  • Experiencing menopause symptoms, which will be assessed by a Menopause Rating Scale (MRS) survey score of ≥ 5
  • Has an upcoming Mayo Clinic primary care appointment within 3 weeks of the enrollment and the MRS survey

Exclusion criteria

  • Lack of willingness to engage with app
  • Inability to provide informed consent

Treatment and study plan

EMMII

Other

The tool/app, consists of educational components designed to enable women to more effectively identify menopause symptoms and feel confident in seeking treatment to address their symptoms. The tool/app also produces a tailored menopause discussion guide for patients to bring to their primary care appointment.

Comparison Group

Other

Receive educational menopause pamphlet describing menopause symptoms and evidence-based treatment options.

Primary outcomes

  1. Frequency of app logins among intervention group.

    Time frame: Up to 6 weeks

  2. Compare differences in rates of menopause treatment among intervention and comparison groups.

    Time frame: Up to 6 weeks

  3. Mean score on a validated survey assessing perceived importance and availability of healthcare services for women's health conditions/concerns related to menopause

    Time frame: through study completion, an average of 1 year

  4. Percentage of healthcare professionals reporting 'high' & 'low' confidence in diagnosing and managing menopause symptoms

    Time frame: through study completion, an average of 1 year

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Official study title

Evaluation of a Mobile Phone Application Tool for Menopause Symptom Management

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Apr 9, 2025
Registry last updated
Jun 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.